Sanofi SA (SAN.PA) — Quality & forensics

As of 2026-10-30 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.

The Closelooknet module scores

58 /100 composite · 7 modules · general weight set

Valuation 59
Quality 69
Growth 42
Balance sheet 52
Cash quality 50
Capital allocation 90
Momentum 56

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.37 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

7/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.58 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the SAN.PA chart & overview

FAQ · from the current data · as of 2026-10-30

Quick answers

What is Sanofi SA's Closelooknet quality reading?

The composite reads 58/100 across 7 modules, as of 2026-10-30: valuation 59, quality 69, growth 42, balance sheet 52, cash quality 50, capital allocation 90, momentum 56. Closelooknet scores are research diary readings, not ratings or investment advice.

What is Sanofi SA's Altman Z-Score?

2.37, which sits in the grey zone (1.81–2.99) as of 2026-10-30. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Sanofi SA's Piotroski F-Score?

7 of 9, as of 2026-10-30. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Sanofi SA's Beneish M-Score indicate?

-2.58 — below the −1.78 manipulation-risk threshold, as of 2026-10-30. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.